Herpes Simplex Virus Type 2 Acquisition Among HIV-1–Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study

Oral and Vaginal Tenofovir for Genital Herpes Simplex Virus Type 2 Shedding in Immunocompetent Women: A Double-Blind, Randomized, Cross-over Trial

(2015) Rachel A. Bender Ignacio et al.   JOURNAL OF INFECTIOUS DISEASES

Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection

(2015) Salim S. Abdool Karim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Daily Oral Tenofovir and Emtricitabine–Tenofovir Preexposure Prophylaxis Reduces Herpes Simplex Virus Type 2 Acquisition Among Heterosexual HIV-1–Uninfected Men and Women

(2014) Connie Celum et al.   ANNALS OF INTERNAL MEDICINE

Daily Oral Emtricitabine/Tenofovir Preexposure Prophylaxis and Herpes Simplex Virus Type 2 among Men Who Have Sex with Men

(2014) Julia L. Marcus et al.   PLoS One

Psychosocial Predictors of Non-Adherence and Treatment Failure in a Large Scale Multi-National Trial of Antiretroviral Therapy for HIV: Data from the ACTG A5175/PEARLS Trial

(2014) Steven A. Safren et al.   PLoS One

Infectious Co-Factors in HIV-1 Transmission Herpes Simplex Virus Type-2 and HIV-1: New Insights and Interventions

(2012) Ruanne V. Barnabas et al.   CURRENT HIV RESEARCH

Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

(2012) Jared M. Baeten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings

(2012) Thomas B. Campbell et al.   PLOS MEDICINE

Topical Tenofovir, a Microbicide Effective against HIV, Inhibits Herpes Simplex Virus-2 Replication

(2011) Graciela Andrei et al.   Cell Host & Microbe

No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults

(2010) Darrell HS Tan et al.   AIDS

Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans

(2010) J Lingappa et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial

(2010) Jairam R Lingappa et al.   LANCET

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

(2010) Robert M. Grant et al.   NEW ENGLAND JOURNAL OF MEDICINE